-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
On August 20, the new crown DNA vaccine ZyCoV-D was approved for emergency use (EUA) in India.
ZyCov-D has shown excellent safety and effectiveness against DNA variants in Phase III clinical trials.
Following the success of the mRNA vaccine at the end of last year, the DNA vaccine was finally successful
Phase III clinical data show that DNA vaccines are effective against Delta variants
Phase III clinical data show that DNA vaccines are effective against Delta variantsThe new crown DNA vaccine ZyCov-D has conducted the country's largest Phase III clinical trial so far in India, involving more than 50 bases and a total of 28,000 subjects
The Phase III clinical trial in India also proved that the new crown DNA vaccine is very safe and tolerable
The principle of DNA vaccines is to design and synthesize DNA plasmids carrying antigen sequences according to the Central dogma of molecular biology, which is transcribed into mRNA in human cells and then translated into proteins to activate the human immune system
There are more than ten new coronavirus DNA vaccines in the world.
There are more than ten new coronavirus DNA vaccines in the world.
In the face of many technological pioneers, why can India achieve a turnaround? The main reason is that the speed of the Phase III clinical trial of the new crown vaccine mainly depends on the incidence of the clinical research country.
It is worth noting that, according to ZyCov-D’s published technical information, it is highly consistent with the sequence design of pGX9501/INO-4800.
The development of DNA vaccine technology and China's accumulation in this field
The development of DNA vaccine technology and China's accumulation in this fieldBoth DNA vaccine technology and mRNA vaccine technology were born in the early 1990s
In terms of the transformation of scientific achievements, Professor DavidB.
In addition to Ai Di Weixin Biopharmaceuticals, many domestic companies and research institutes have joined the research and development of various DNA vaccines
DNA vaccine and mRNA vaccine, the dual future of nucleic acid vaccine
DNA vaccine and mRNA vaccine, the dual future of nucleic acid vaccineDNA vaccines and mRNA vaccines are called "third-generation" nucleic acid vaccine technologies
At the end of 2020, two mRNA vaccines of BioNTech and Moderna were approved for the prevention of new coronary pneumonia.
With the addition of DNA vaccines, the era of nucleic acid vaccines has come